1
Until more data are available, clinicians should approach combination antifungal therapy with caution.
2
The impact of prompt antifungal therapy in these patients is unknown.
3
Prompt institution of appropriate antifungal therapy is paramount for the management of this condition.
4
Six patients who were administered corticosteroids acquired fungal infections but recovered after antifungal therapy.
5
Combination antifungal therapy is conceptually attractive as a life-saving measure.
6
Primary cutaneous mold infections are treated with systemic antifungal therapy and sometimes with debridement.
7
Treatment requires prompt antifungal therapy and extensive surgical debridement.
8
Treatment with oral steroids is usually necessary and courses of antifungal therapy may improve asthma symptoms.
9
Response to antifungal therapy alone is often inadequate.
10
Separate blood samples for culture and serum PCR were taken before the start of antifungal therapy.
11
Delay in initiating antifungal therapy was common.
12
The response to antifungal therapy was dramatic.
13
CCL24 levels were higher after 36 months of antifungal therapy in PCM patients.
14
Serum cryptococcal antigen was positive in all patients and gradually declined after the institution of the antifungal therapy.
15
Therapy is with systemic antifungal therapy.
16
This case highlights the importance of attention for Exophiala infection in immunocompromised individuals in those given antifungal therapy with echinocandins.
